Bristol-Myers Squibb Company (BMY) Financial Statements (2024 and earlier)

Company Profile

Business Address ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,25316,96615,83115,3938,8846,812
Cash and cash equivalents9,12313,97914,54612,3466,9115,421
Short-term investments1302,9871,2853,0471,9731,391
Receivables9,8869,3698,5017,6855,9656,300
Inventory, net of allowances, customer advances and progress billings2,3392,0952,0744,2931,1951,166
Inventory2,3392,0952,0744,2931,1951,166
Other current assets5,7954,8323,7861,9831,116576
Total current assets:27,27333,26230,19229,35417,16014,854
Noncurrent Assets
Inventory, Noncurrent     429422
Property, plant and equipment6,2556,0495,8866,2525,0275,001
Long-term investments and receivables   4337671,7752,480
Long-term investments   4337671,7752,480
Intangible assets, net (including goodwill)57,00863,02973,79086,4577,6298,073
Goodwill21,14920,50220,54722,4886,5386,863
Intangible assets, net (excluding goodwill)35,85942,52753,24363,9691,0911,210
Deferred income tax assets1,3441,4391,161 
Other noncurrent assets4,9405,5357,0196,6042,0241,533
Other undisclosed noncurrent assets   5109421,188
Total noncurrent assets:69,54776,05288,289100,59017,82618,697
TOTAL ASSETS:96,820109,314118,481129,94434,98633,551
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,0402,9492,7132,4458,7798,493
Taxes payable   398231
Accounts payable3,0402,9492,7132,4451,8922,248
Accrued liabilities     6,4896,014
Debt4,2644,9482,3403,3461,703987
Deferred revenue and credits83
Other liabilities14,58613,97114,02712,513  
Other undisclosed current liabilities     172 
Total current liabilities:21,89021,86819,08018,30410,6549,563
Noncurrent Liabilities
Long-term debt and lease obligation35,05639,60548,33643,3875,6466,975
Long-term debt, excluding current maturities35,05639,60548,33643,3875,6466,975
Liabilities, other than long-term debt8,75611,83513,18316,5554,1095,166
Deferred revenue and credits454
Accounts payable and accrued liabilities     3,0433,548
Deferred tax liabilities, net18 
Deferred income tax liabilities2,1664,5015,4076,454
Other liabilities6,5907,3347,77610,1011,0481,164
Other undisclosed noncurrent liabilities     450 
Total noncurrent liabilities:43,81251,44061,51959,94210,20512,141
Total liabilities:65,70273,30880,59978,24620,85921,704
Equity
Equity, attributable to parent31,06135,94637,82251,59814,03111,741
Common stock 292292292292221221
Treasury stock, value(38,618)(31,259)(26,237)(25,357)(19,574)(19,249)
Additional paid in capital45,16544,36144,32543,7092,0811,898
Accumulated other comprehensive loss(1,281)(1,268)(1,839)(1,520)(2,762)(2,289)
Retained earnings25,50323,82021,28134,47434,06531,160
Other undisclosed equity, attributable to parent      
Equity, attributable to noncontrolling interest57606010096106
Total equity:31,11836,00637,88251,69814,12711,847
TOTAL LIABILITIES AND EQUITY:96,820109,314118,481129,94434,98633,551

Income Statement (P&L) ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues46,15946,38542,51826,14522,56120,776
Revenue, net20,776
Cost of revenue(21,123)(19,243)(30,585)(10,151)(6,547)(6,066)
Cost of goods and services sold(10,137)(9,940)(11,773)(8,078)(6,547)(6,066)
Other undisclosed gross profit   18,8122,073  
Gross profit:25,03627,14230,74518,06716,01414,710
Operating expenses(17,323)(19,044)(18,804)(11,019)(10,896)(11,098)
Operating income:7,7138,09811,9417,0485,1183,612
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(576)7202,314(938)8501,519
Interest and debt expense(266)(281)(1,420)(656)(183)(109)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  (19,706)(479)183109
Income (loss) from continuing operations before equity method investments, income taxes:6,8718,537(6,871)4,9755,9685,131
Income from equity method investments      
Other undisclosed income (loss) from continuing operations before income taxes842(439)    
Income (loss) from continuing operations before income taxes:7,7138,098(6,871)4,9755,9685,131
Income tax expense(1,368)(1,084)(2,124)(1,515)(1,021)(4,156)
Income (loss) from continuing operations:6,3457,014(8,995)3,4604,947975
Income (loss) before gain (loss) on sale of properties:7,014(8,995)3,4604,947975
Net income (loss):6,3457,014(8,995)3,4604,947975
Net income (loss) attributable to noncontrolling interest (18)(20)(20)(21)(27)32
Other undisclosed net loss attributable to parent      
Net income (loss) available to common stockholders, diluted:6,3276,994(9,015)3,4394,9201,007

Comprehensive Income ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):6,3457,014(8,995)3,4604,947975
Other comprehensive income (loss)(13)571(319)1,242(156)214
Comprehensive income (loss):6,3327,585(9,314)4,7024,7911,189
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(18)(20)(20)(21)(27)32
Comprehensive income (loss), net of tax, attributable to parent:6,3147,565(9,334)4,6814,7641,221

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: